
Scientists from the Indian Institute of Technology Madras (IIT-M) and NASA's Jet Propulsion Laboratory (JPL) collaborated to study the behaviour of multi-drug-resistant pathogens (Enterobacter Bugandensis) aboard the International Space Station (ISS).
About Enterobacter Bugandensis:
- Enterobacter bugandensis is a relatively novel species within the Enterobacter genus.
- Discovered in 2013, it was isolated from cases of bloodstream infections in Uganda.
Key Characteristics:
- Morphology: Gram-negative, rod-shaped bacterium.
- Habitat: Found in various environments, including soil, water, and the gastrointestinal tracts of animals and humans, similar to other Enterobacter species.
- Pathogenicity: Primarily affects immunocompromised individuals, causing infections such as bloodstream infections, respiratory infections, urinary tract infections, and wound infections.
- Resistance: E. bugandensis exhibits resistance to multiple antibiotics, making treatment challenging.
- Resistance mechanisms include beta-lactamase production, efflux pumps, and mutations that reduce drug uptake.
Multi-drug-Resistant Pathogens:
- Definition: Multi-drug-resistant (MDR) pathogens are microorganisms that have developed resistance to several antimicrobial agents, usually three or more antimicrobial categories.
- Types: MDR can occur in various microorganisms, including bacteria, viruses, and parasites.
Antibiotic Resistance:
- Definition: Antibiotic resistance is the ability of bacteria to survive exposure to antibiotics that would normally kill or inhibit their growth.
- Significance: Antibiotic resistance poses a significant global health concern.